Clinical trial
Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
NCT00201292 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
- Lead sponsor
- National Health Research Institutes, Taiwan
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2005
- Completion date
- October 31, 2008
- Enrollment
- 1,350 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, metabolic syndrome